Sign In
Buy FMS
$25.66
-0.0400 (-0.156%)
At Close: Jul 31, 2026
The Ensign Group (ENSG) Gets a Buy Rating from RBC Capital
01:34pm, Monday, 20'th Apr 2020
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on The Ensign Group (ENSG), with a price target of $48.00. The company's
The Ensign Group (ENSG) Gets a Buy Rating from RBC Capital
01:33pm, Monday, 20'th Apr 2020
In a report released today,
Frank Morgan
from RBC Capital maintained a
Buy
rating on The Ensign Group (
ENSG
–
Research Report
), with a price target of
$48.00
. The company’s shares closed last M
RBC Capital Maintains Their Hold Rating on DaVita (DVA)
01:33pm, Monday, 20'th Apr 2020
RBC Capital analyst Frank Morgan maintained a Hold rating on DaVita (DVA) today and set a price target of $75.00. The company's shares closed last Monday
RBC Capital Maintains Their Hold Rating on DaVita (DVA)
01:33pm, Monday, 20'th Apr 2020
RBC Capital analyst
Frank Morgan
maintained a
Hold
rating on DaVita (
DVA
–
Research Report
) today and set a price target of
$75.00
. The company’s shares closed last Monday at $77.20.
According
RBC Capital Keeps Their Buy Rating on Encompass Health (EHC)
01:33pm, Monday, 20'th Apr 2020
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Encompass Health (EHC), with a price target of $84.00. The company's
RBC Capital Keeps Their Buy Rating on Encompass Health (EHC)
01:33pm, Monday, 20'th Apr 2020
In a report released today,
Frank Morgan
from RBC Capital maintained a
Buy
rating on Encompass Health (
EHC
–
Research Report
), with a price target of
$84.00
. The company’s shares closed last Mo
RBC Capital Keeps Their Buy Rating on Addus Homecare (ADUS)
01:33pm, Monday, 20'th Apr 2020
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on Addus Homecare (ADUS), with a price target of $98.00. The company's
RBC Capital Keeps Their Buy Rating on Addus Homecare (ADUS)
01:33pm, Monday, 20'th Apr 2020
In a report released today,
Frank Morgan
from RBC Capital maintained a
Buy
rating on Addus Homecare (
ADUS
–
Research Report
), with a price target of
$98.00
. The company’s shares closed last Fri
LHC Group (LHCG) Gets a Buy Rating from RBC Capital
01:33pm, Monday, 20'th Apr 2020
In a report released today, Frank Morgan from RBC Capital maintained a Buy rating on LHC Group (LHCG), with a price target of $173.00. The company's
Amedisys (AMED) Receives a Buy from RBC Capital
01:33pm, Monday, 20'th Apr 2020
RBC Capital analyst Frank Morgan maintained a Buy rating on Amedisys (AMED) today and set a price target of $218.00. The company's shares closed last
Analysts' Opinions Are Mixed on These Healthcare Stocks: Chemed (CHE) and Regeneron (REGN)
01:32pm, Monday, 20'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Chemed (CHE) and Regeneron (REGN). Chemed (CHE) RBC Capital analyst
Here's How P/E Ratios Can Help Us Understand Fresenius Medical Care AG & Co. KGaA (ETR:FME)
07:19am, Monday, 20'th Apr 2020
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). We'll apply a basic P/E...
Arden Trust Co Takes Position in Fresenius Medical Care AG & Co. (NYSE:FMS)
10:16am, Sunday, 19'th Apr 2020
Arden Trust Co bought a new stake in Fresenius Medical Care AG & Co. (NYSE:FMS) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. Th
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Fresenius Medical Care Holdings, Inc. Frankfurt am Main, April 17, 2020 -- Moody's Investors Service (
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Fresenius Medical Care AG & Co. KGaA and other ratings that are associated with the same analytical unit. The r
